J Korean Soc Neonatol. Search


Neonatal Med > Volume 18(1); 2011 > Article
Journal of the Korean Society of Neonatology 2011;18(1):34-41.
DOI: https://doi.org/10.5385/jksn.2011.18.1.34    Published online May 15, 2011.
Anticoagulation Therapy, Thrombolytic Therapy, and Use of Blood Products in Neonates.
Chang Won Choi
Department of Pediatrics, Seoul National University College of Medicine, Seoul, Korea. choicw@snu.ac.kr
Neonatal coagulation disorders and thromboembolism require timely management. Failure to treat these conditions at the appropriate time may lead to death or the development of significant long-term sequelae. However, most current guidelines for managing neonatal coagulation disorders and thromboembolism are empiric and not based on randomized clinical trials. Thus, it is not easy to choose an appropriate management strategy for these conditions in clinical settings. In this review, therapeutic guidelines currently utilized in clinics and novel therapeutic options still under investigation are presented and reviewed.
Key Words: Neonate; Coagulation disorder; Thromboembolism; Anti-coagulation therapy
Share :
Facebook Twitter Linked In Google+ Line it
METRICS Graph View
  • 0 Crossref
  • 2,980 View
  • 11 Download
Related article in NM

Anticonvulsant Therapy in Neonate.2009 May;16(1)


Browse all articles >

Editorial Office
34, Sajik-ro 8–gil(King’s Gargen 3 Block 1207), Jongno-gu, Seoul 03174, Republic of Korea
Tel: +82-2-730-1993    Fax: +82-2-730-1994    E-mail: neonate2002@naver.com                

Copyright © 2023 by The Korean Society of Neonatology.

Developed in M2PI

Close layer
prev next